What is the recommended dosage of Amoxicillin (Amoxycillin) for a pediatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin Dosing for Pediatric Patients

For most common pediatric infections, amoxicillin should be dosed at 45 mg/kg/day divided into 2 doses (every 12 hours), with higher dosing of 90 mg/kg/day in 2 doses reserved for severe infections, high-resistance areas, or specific risk factors. 1

Standard Dosing Algorithm

Weight-based dosing is essential and should always be used rather than age-based approximations for accurate and safe prescribing. 1, 2

Mild to Moderate Infections

  • 45 mg/kg/day divided every 12 hours for uncomplicated respiratory tract infections, skin infections, and genitourinary infections in children ≥3 months old and weighing <40 kg 1
  • This provides adequate coverage for most susceptible pathogens including Streptococcus pneumoniae, Haemophilus influenzae (non-β-lactamase producing), and Streptococcus pyogenes 1
  • Treatment duration is typically 7-10 days for most respiratory infections 1

High-Dose Regimen (90 mg/kg/day)

Use 90 mg/kg/day divided every 12 hours when any of the following risk factors are present: 1

  • Community-acquired pneumonia in areas with >10% penicillin-resistant S. pneumoniae
  • Children <2 years old
  • Recent antibiotic exposure within the past 30 days
  • Daycare attendance
  • Severe infections requiring hospitalization
  • Incomplete Haemophilus influenzae type b vaccination

Maximum Daily Dose

  • Do not exceed 4000 mg/day regardless of weight 1

Indication-Specific Dosing

Community-Acquired Pneumonia

  • Mild to moderate (outpatient): 45 mg/kg/day divided every 12 hours 1
  • Severe or high-resistance areas: 90 mg/kg/day divided every 12 hours 1
  • Treatment duration: 10 days 1
  • Clinical improvement should be evident within 48-72 hours; if no improvement occurs, reevaluation is necessary 1

Group A Streptococcal Pharyngitis (Scarlet Fever)

  • 50-75 mg/kg/day divided into 2 doses for 10 days 1
  • Maximum single dose: 1000 mg 1
  • Patients become non-contagious after 24 hours of antibiotic therapy 1

Acute Bacterial Sinusitis

  • Children ≥2 years without risk factors: 45 mg/kg/day divided every 12 hours 1
  • Children <2 years, in daycare, or with recent antibiotic use: 80-90 mg/kg/day divided every 12 hours 1

When to Use Amoxicillin-Clavulanate Instead

Switch to amoxicillin-clavulanate (90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate) for: 1, 3

  • β-lactamase-producing organisms (H. influenzae, M. catarrhalis)
  • Treatment failure after 48-72 hours on amoxicillin alone
  • Recent antibiotic use within the past 4-6 weeks
  • Incomplete H. influenzae type b vaccination with concurrent purulent otitis media

Practical Dosing Examples

Example 1: 3-Month-Old Infant (5.5 kg) with Pneumonia

  • Mild to moderate: 45 mg/kg/day = 247.5 mg/day ÷ 2 = 124 mg per dose (approximately 1.25 mL of 250 mg/5 mL suspension twice daily) 1
  • Severe or high resistance: 90 mg/kg/day = 495 mg/day ÷ 2 = 247.5 mg per dose (approximately 2.5 mL twice daily) 1

Example 2: 5-Year-Old Child (18 kg) with Strep Throat

  • 50-75 mg/kg/day = 900-1350 mg/day ÷ 2 = 450-675 mg per dose 1
  • Using 400 mg/5 mL suspension: approximately 5.6-8.4 mL twice daily (not exceeding 1000 mg per dose) 1

Example 3: 8-Year-Old Child (44.5 kg) with Pharyngitis

  • 50-75 mg/kg/day = 2225-3337.5 mg/day, but maximum 1000 mg per dose 1
  • Administer 1000 mg twice daily for 10 days 1

Critical Monitoring Points

  • Expect clinical improvement within 48-72 hours of starting therapy 1
  • If no improvement or worsening occurs after 72 hours, reassess diagnosis and consider:
    • Atypical pathogens requiring macrolide addition 1
    • Complications or alternative diagnoses 1
    • Switch to amoxicillin-clavulanate for β-lactamase-producing organisms 1

Common Pitfalls to Avoid

  1. Using age-based rather than weight-based dosing leads to under- or overdosing 2
  2. Underdosing in high-resistance areas or with risk factors promotes treatment failure and antimicrobial resistance 1
  3. Prescribing antibiotics for viral URTIs increases adverse effects without benefit 3
  4. Stopping treatment early when symptoms improve before completing the full course 1
  5. Not documenting weight, daily dose, number of divided doses, duration, and indication on prescriptions leads to dispensing errors 2

Alternative Treatments for Penicillin Allergy

  • Non-anaphylactic reactions: Second- or third-generation cephalosporins (cefdinir, cefuroxime) 1
  • Serious penicillin allergy (Type I hypersensitivity): Levofloxacin, moxifloxacin, or linezolid 1

Evidence Quality Note

The dosing recommendations are based on high-quality guidelines from the American Academy of Pediatrics and Infectious Diseases Society of America 1, with supporting evidence from recent randomized controlled trials demonstrating that twice-daily dosing is as effective as three-times-daily dosing for equivalent total daily doses 4, 5, 6. The CAP-IT trial (2021) demonstrated that lower-dose amoxicillin (35-50 mg/kg/day) was noninferior to higher dose (70-90 mg/kg/day) in unselected children with CAP, though disease severity and prior antibiotic exposure require consideration 6.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.